NeurosciencePLoS ONEPeer-reviewed
Mitochondrial dysfunction underlying sporadic inclusion body myositis is ameliorated by the mitochondrial homing drug MA-5
Yoshitsugu Oikawa, Rumiko Izumi, Masashi Koide…·Takaaki Abe
This study identifies mitochondrial dysfunction in sporadic inclusion body myositis and shows that MA-5 improves mitochondrial function and protects myoblasts.
37 citations